Skip to Content
Merck
CN
  • Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro.

Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro.

Bioorganic & medicinal chemistry (2008-04-15)
Saverio Cellamare, Angela Stefanachi, Diana A Stolfa, Teodora Basile, Marco Catto, Francesco Campagna, Eddy Sotelo, Pasquale Acquafredda, Angelo Carotti
ABSTRACT

A series of N-terminus benzamides of glycine-based symmetric peptides, linked to m-xylylenediamine and 3,4'-oxydianiline spacers, were prepared and tested as inhibitors of beta-amyloid peptide Abeta(1-40) aggregation in vitro. Compounds with good anti-aggregating activity were detected. Polyphenolic amides showed the highest anti-aggregating activity, with IC(50) values in the micromolar range. Structure-activity relationships suggested that pi-pi stacking and hydrogen-bonding interactions play a key role in the inhibition of Abeta(1-40) self-assembly leading to amyloid fibrils.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
m-Xylylenediamine, 99%